Nantahala Capital Management is a hedge fund.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Nantahala Capital Management is a hedge fund.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2022 | immatics biotechnologies | Post-IPO Equity | 0 |
9/2021 | Keystone Dental | Venture Round | 25M |
3/2023 | Unicycive Therapeutics | Post-IPO Equity | 0 |
1/2021 | DarioHealth | Post-IPO Equity | 70M |
4/2022 | Lyra Therapeutics | Post-IPO Equity | 0 |
9/2021 | Disc Medicine | Post-IPO Equity | 0 |
9/2021 | Disc Medicine | Series B | 90M |
9/2020 | Silverback Therapeutics | Series C | 85M |
5/2023 | Lyra Therapeutics | Post-IPO Equity | 0 |
11/2022 | Abeona Therapeutics | Post-IPO Equity | 0 |
7/2020 | DarioHealth | Post-IPO Equity | 28.6M |
4/2022 | Lyra Therapeutics | Post-IPO Equity | 0 |
9/2021 | Disc Medicine | Series B | 0 |
9/2021 | Keystone Dental | Venture Round | 0 |
1/2021 | DarioHealth | Post-IPO Equity | 0 |
9/2020 | Silverback Therapeutics | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|